240 studies found for:
"Anemia, Aplastic"
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Eltrombopag for Moderate Aplastic Anemia
|
||||
| 2 | Recruiting |
Efficacy and Safety of Eltrombopag In Patients With Severe and Very Severe Aplastic Anemia
|
||||
| 3 | Completed |
A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia
|
||||
| 4 | Active, not recruiting |
Cyclophosphamide Plus Cyclosporine in Treatment-na ve Severe Aplastic Anemia
|
||||
| 5 | Recruiting |
Alemtuzumab to Treat Severe Aplastic Anemia
|
||||
| 6 | Recruiting |
Allogeneic Stem Cell Transplantation for Patients With Severe Aplastic Anemia
|
||||
| 7 | Unknown † |
Safety and Efficacy Study of Ex Vivo Immunotherapy for Treatment of Aplastic Anemia
|
||||
| 8 | Recruiting |
Fludarabine-based Conditioning for Severe Aplastic Anemia
|
||||
| 9 |
Completed
Has Results |
Partially Matched Stem Cell Transplantation for Patients With Refractory Severe Aplastic Anemia or Refractory Cytopenias
|
||||
| 10 | Recruiting |
Horse ATG/CsA in Aplastic Anemia Patients Unresponsive to or With a Suboptimal Response to Rabbit ATG/CsA Treatment
|
||||
| 11 | Completed |
Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia
|
||||
| 12 | Recruiting |
A Pilot Study of a Thrombopoietin-Receptor Agonist (TPO-R Agonist), Eltrombopag, in Aplastic Anemia Patients With Immunosuppressive-Therapy Refractory Thrombocytopenia
|
||||
| 13 | Unknown † |
Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia
|
||||
| 14 | Completed |
Conditioning Regimens for Patients With Severe Aplastic Anemia Transplanted With Marrow From an Unrelated Donor
|
||||
| 15 | Active, not recruiting |
Flu+CPM+rATG Conditioning Regimes for Unrelated Bone Marrow Transplantation (UBMT)(or Mobilized Peripheral Blood)in Severe Aplastic Anemia (SAA)
|
||||
| 16 | Suspended |
Alefacept in Patients With Relapsed/Refractory Aplastic Anemia
|
||||
| 17 | Completed |
Collection of Biological Samples From Patients With Hepatitis-Associated Aplastic Anemia
|
||||
| 18 | Recruiting |
Alemtuzumab and Rituximab in Aplastic Anemia
|
||||
| 19 | Completed |
Neuropsychological Effects of Immunosuppressive Treatment in Subjects With Aplastic Anemia
|
||||
| 20 | Recruiting |
Mesenchymal Stem Cells in the Treatment of Relapsed/Refractory Severe Acquired Aplastic Anemia
|
† Indicates status has not been verified in more than two years
